I would never question my hon. Friend’s intentions in this area, but the AMRC’s summary states:
“we do not see the need for this legislation and do not believe the Bill will achieve its aim of encouraging medical innovation.”
It goes on to say that
“this Bill…as it stands is unnecessary and may adversely impact on patients and medical research”.
That view is supported, among others, by Cancer Research UK, the British Heart Foundation and the Wellcome Trust. Does that not give him pause for thought before he proceeds with the Bill?